The cost of Russian vaccines for the coronavirus infection Sputnik V and EpiVacCorona is almost the same. This was announced by Rinat Maksyutov, Director General of the Vector Center for Virology and Biotechnology, during the Science Bar Hopping online festival. TASS.
“According to my data, now, when calculating the production capacity of their [одной дозы вакцин «Спутник V» и «ЭпиВакКорона»] the cost is practically the same, ”said Maksyutov.
According to him, “Vector” has already produced 35 thousand doses of the drug, by the end of the year this number will increase to 50 thousand. Of these, about 5 thousand doses went to post-registration clinical trials, and the rest will be introduced into civil circulation.
“In December, we expect the introduction of most of them into civil circulation,” said Maksyutov. He added that the first series of drugs, which will enter the civilian circulation, will be tested in the institutions of the Ministry of Health no earlier than December 7-8.